Targeting intratumoral hypoxia to enhance anti-tumor immunity
Seminars in Cancer Biology · 2023-11 · 96 · 5-10
DOI: 10.1016/j.semcancer.2023.09.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-11. Verfasst von Gregg L Semenza. Beteiligte Einrichtung: Department of Genetic Medicine, Institute for Cell Engineering, and Armstrong Oxygen Biology Research Center, Johns Hopkins University School of Medi…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetic Medicine, Institute for Cell Engineering, and Armstrong Oxygen Biology Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: gsemenza@jhmi.edu.
Zitieren
APA
Semenza, G. L. (2023). Targeting intratumoral hypoxia to enhance anti-tumor immunity. Seminars in Cancer Biology, 96, 5-10. https://doi.org/10.1016/j.semcancer.2023.09.002
Vancouver
Semenza GL. Targeting intratumoral hypoxia to enhance anti-tumor immunity. Seminars in Cancer Biology. 2023;96:5-10. doi:10.1016/j.semcancer.2023.09.002
BibTeX
@article{Semenza2023,
author = {Semenza, Gregg L},
title = {Targeting intratumoral hypoxia to enhance anti-tumor immunity},
journal = {Seminars in Cancer Biology},
year = {2023},
volume = {96},
pages = {5--10},
doi = {10.1016/j.semcancer.2023.09.002}
}
EUVIMED